إعلان
إعلان

KZIA

KZIA logo

Kazia Therapeutics Limited - ADR

6.80
USD
برعاية
+0.02
+0.24%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

6.78

-0.02
-0.24%

تقارير أرباح KZIA

النسبة الإيجابية المفاجئة

KZIA تفوق 2 من 5 آخر التقديرات.

40%

التقرير التالي

بيانات التقرير القادم
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
التغير الضمني من Q4 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q-- -1 (Revenue/ EPS)
--
/
--

Kazia Therapeutics Limited - ADR earnings per share and revenue

On ٠٧ نوفمبر ٢٠٢٥, KZIA reported earnings of 1.42 USD per share (EPS) for Q4 25, beating the estimate of -1.32 USD, resulting in a 207.09% surprise. Revenue reached 42.00 ألف, compared to an expected 8.16 ألف, with a 414.71% difference. The market reacted with a +0.82% price change (close before vs. close after earnings).
Looking ahead to -- --, -- المحللين forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q4 2025, Kazia Therapeutics Limited - ADR reported EPS of $1.42, beating estimates by 207.09%, and revenue of $42.00K, 414.71% above expectations.
The stock price moved up 0.82%, changed from $7.33 before the earnings release to $7.39 the day after.
The next earning report is scheduled for --.
Based on -- المحللين, Kazia Therapeutics Limited - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان